[ad_1] The Israeli dermatology company Sol-Gel (Nasdaq: SLGL) has announced that it will develop another generic product in cooperation with the company Perrigo (NYSE: PRGO; TASE: PRGO). Sol-Gel has developed a method …
Read More »Court rejects Allergan's tribal licensing strategy, striking another blow to its generic Restasis defense
[ad_1] A Federal Court of Appeal Rejected Allergan's Attempt to Apply Sovereign Immunity to Patent Examinations . (Go to Pixabay) Allergan has been the subject of harsh criticism on his attempt to …
Read More »